A notable limitation was that 82% of patients developed anti-drug antibodies and 10% exhibited neutralizing antibodies, which could potentially compromise treatment efficacy and tolerability
Studies have explored the impact of FSHD on health-related quality of life (HRQoL) using a plethora of patient reported outcome measures (PROMs)
Study Participants Participants aged 18 years, diagnosed with T2D, who were treatment-nave to injectable glucose-lowering drug(s) except for short-term insulin treatment for acute illness lasting for a total of 14 days, and who had an available HbA1c value within 90 days prior to visit (V) 1 or taken at V1 in line with local clinical practice, were included
How Semaglutide Helps Men with Type 2 Diabetes Managing type 2 diabetes can be challenging, especially when it comes to controlling blood sugar and losing weight
The medication graph turns the weekly cycle into something visible, so you can connect shot day, appetite changes, stomach symptoms, and food logging to the right part of the week